Performance of the Universal Vital Assessment (UVA) mortality risk score in hospitalized adults with infection in Rwanda: A retrospective external validation study.

Autor: Hazard R; University of Melbourne, School of Population and Global Health, Melbourne, Australia., Bagenda D; Department of Anesthesiology, University of Nebraska Medical Center, Omaha, NE, United States of America., Patterson AJ; Department of Anesthesiology, Emory University, Atlanta, GA, United States of America., Hoffman JT; Department of Anesthesiology, University of Nebraska Medical Center, Omaha, NE, United States of America., Lisco SJ; Department of Anesthesiology, University of Nebraska Medical Center, Omaha, NE, United States of America., Urayeneza O; University of Gitwe, School of Medicine, Gitwe, Rwanda.; Department of Surgery, California Hospital Medical Center, Los Angeles, CA, United States of America., Ntihinyurwa P; Department of Obstetrics and Gynecology, University of Rwanda, Kigali, Rwanda., Moore CC; Division of Infectious Diseases and International Health, Department of Medicine, University of Virginia, Charlottesville, VA, United States of America.
Jazyk: angličtina
Zdroj: PloS one [PLoS One] 2022 Mar 23; Vol. 17 (3), pp. e0265713. Date of Electronic Publication: 2022 Mar 23 (Print Publication: 2022).
DOI: 10.1371/journal.pone.0265713
Abstrakt: Background: We previously derived a Universal Vital Assessment (UVA) score to better risk-stratify hospitalized patients in sub-Saharan Africa, including those with infection. Here, we aimed to externally validate the performance of the UVA score using previously collected data from patients hospitalized with acute infection in Rwanda.
Methods: We performed a secondary analysis of data collected from adults ≥18 years with acute infection admitted to Gitwe District Hospital in Rwanda from 2016 until 2017. We calculated the UVA score from the time of admission and at 72 hours after admission. We also calculated quick sepsis-related organ failure assessment (qSOFA) and modified early warning scores (MEWS). We calculated amalgamated qSOFA scores by inserting UVA cut-offs into the qSOFA score, and modified UVA scores by removing the HIV criterion. The performance of each score determined by the area under the receiver operator characteristic curve (AUC) was the primary outcome measure.
Results: We included 573 hospitalized adult patients with acute infection of whom 40 (7%) died in-hospital. The admission AUCs (95% confidence interval [CI]) for the prediction of mortality by the scores were: UVA, 0.77 (0.68-0.85); modified UVA, 0.77 (0.68-0.85); qSOFA, 0.66 (0.56-0.75), amalgamated qSOFA, 0.71 (0.61-0.80); and MEWS, 0.74 (0.64, 0.83). The positive predictive values (95% CI) of the scores at commonly used cut-offs were: UVA >4, 0.35 (0.15-0.59); modified UVA >4, 0.35 (0.15-0.59); qSOFA >1, 0.14 (0.07-0.24); amalgamated qSOFA >1, 0.44 (0.20-0.70); and MEWS >5, 0.14 (0.08-0.22). The 72 hour (N = 236) AUC (95% CI) for the prediction of mortality by UVA was 0.59 (0.43-0.74). The Chi-Square test for linear trend did not identify an association between mortality and delta UVA score at 72 hours (p = 0.82).
Conclusions: The admission UVA score and amalgamated qSOFA score had good predictive ability for mortality in adult patients admitted to hospital with acute infection in Rwanda. The UVA score could be used to assist with triage decisions and clinical interventions, for baseline risk stratification in clinical studies, and in a clinical definition of sepsis in Africa.
Competing Interests: The authors have declared that no competing interests exist.
Databáze: MEDLINE
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje